Br J Psychiatry
- ABBOUD F, Ahrens J, Balles E, Bambini V, et al
The functional relevance of a short assessment of formal thought disorder in
psychosis.
Br J Psychiatry. 2026 May 26:1-9. doi: 10.1192/bjp.2026.10650.
- GHENCIULESCU A, Pearse A, Minichino A, Sampogna G, et al
Transdiagnostic efficacy of lurasidone on depressive symptoms: systematic review
and meta-analysis of randomised controlled trials.
Br J Psychiatry. 2026;228:357-366.
- WAGNER E, Korman N, Solmi M, Mortazavi M, et al
Multidisciplinary consensus on prevention, screening and monitoring of
clozapine-associated myocarditis and clozapine rechallenge after myocarditis.
Br J Psychiatry. 2026;228:348-356.
- LAUNDERS N, Jackson CA, Hayes JF, John A, et al
Characteristics of people with severe mental illness excluded from incentivised
physical health checks in the UK: electronic healthcare record study.
Br J Psychiatry. 2026;228:340-347.
J Clin Psychopharmacol
- MISAWA F, Takeuchi H
Therapeutic Interventions and Clinical Outcomes Following Breakthrough Psychosis
on Antipsychotic Maintenance Medication (BAMM): A Retrospective Chart Review.
J Clin Psychopharmacol. 2026 May 28. doi: 10.1097/JCP.0000000000002196.
Neuropsychopharmacology
- PARKER N, Koch E, Shadrin AA, Fuhrer J, et al
Leveraging the genetics of psychiatric disorders to prioritize potential drug
targets and compounds.
Neuropsychopharmacology. 2026;51:1300-1309.
Pharmacopsychiatry
- ACUNA M, Martin-Munoz JC, Munoz MJ, Casado FD, et al
A Naturalistic Study on the Cost Reduction and Efficacy of Long-acting
Antipsychotics in an Early Intervention Programme for Patients with Recent-onset
Psychosis.
Pharmacopsychiatry. 2026 May 29. doi: 10.1055/a-2865-3839.
Psychol Med
- UNZUETA J, Mathias S, Lanzagorta N, Mollon J, et al
Evaluating psychosis-specific effects of trauma exposure in early-onset and
adult-onset psychosis.
Psychol Med. 2026;56:e168.
- TAKEKITA Y, Katsumoto E, Adachi N, Kubota Y, et al
Factors associated with social functioning by relapse frequency in Japanese
outpatients with schizophrenia: the Multicenter Treatment Survey and Assessments
for Schizophrenia in Psychiatric Clinics (MUSASI).
Psychol Med. 2026;56:e159.
- CHEN PC, Pan YJ, Lin MC, Su MH, et al
Familial coaggregation and shared genetic loading of mental disorders and
cardiovascular diseases.
Psychol Med. 2026;56:e164.
- LU C, Dong Y, Zhai Z, Gao T, et al
Predicting functional remission after antipsychotic discontinuation: a real-world
study in schizophrenia.
Psychol Med. 2026;56:e167.
Schizophr Res
- CRABTREE E, Brock E, Lewandowski KE
Elevated impulsivity in psychosis is associated with mood, anxiety, and general
symptoms.
Schizophr Res. 2026;295:120-128.
- LINDENMAYER JP, Khan A, Insel BJ, Kothare H, et al
Psychometric analysis of speech-based digital biomarkers of alogia symptoms in
treatment resistant schizophrenia: Comparison with clinical ratings of expressive
negative symptoms.
Schizophr Res. 2026;295:110-119.
- ATAOV G, Balaban OD, Cirakli Z, Yesilkaya UH, et al
Can electroconvulsive therapy attenuate glial stress in schizophrenia?
Longitudinal evidence from serum GFAP and S100B.
Schizophr Res. 2026;295:91-100.
- HOLKER J, Clouse A, Gilday SAJ, Jensen J, et al
Motivation and pleasure deficits reflect altered network embedding of normal
brain deviations in schizophrenia.
Schizophr Res. 2026;295:82-90.
- WU M, Li Z, Wang Y, Zhang X, et al
A network analysis of psychotic symptoms, neurocognition, alexithymia, empathy,
and suicidal intent in patients with chronic schizophrenia.
Schizophr Res. 2026;295:72-81.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016